Original article
Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project
Caracterización del manejo del paciente con migraña en Atención Primaria en España. Análisis de los resultados del proyecto europeo My-LIFE anamnesis
S. Díaz-Insaa,
, M. Navarro-Zornozab, R. Sánchez-de la Rosac, A.L. Guerrerod,e,f
Corresponding author
a Unidad de Cefaleas, Neurología, Hospital Universitari i Politècnic La Fe, IIS La Fe, Valencia, Spain
b Medical Department, Novartis Pharmaceuticals, Barcelona, Spain
c Novartis Pharma AG, Region Europe Medical Dpt, Basel, Switzerland
d Unidad de Cefaleas, Servicio de Neurología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
e Departamento de Medicina, Universidad de Valladolid, Valladolid, Spain
f Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
Read
2888
Timeswas read the article
533
Total PDF
2355
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 43 | 5 | 48 |
| 2025 11 | 195 | 65 | 260 |
| 2025 10 | 211 | 26 | 237 |
| 2025 9 | 123 | 23 | 146 |
| 2025 8 | 94 | 38 | 132 |
| 2025 7 | 122 | 25 | 147 |
| 2025 6 | 110 | 18 | 128 |
| 2025 5 | 90 | 28 | 118 |
| 2025 4 | 113 | 8 | 121 |
| 2025 3 | 69 | 12 | 81 |
| 2025 2 | 63 | 5 | 68 |
| 2025 1 | 70 | 18 | 88 |
| 2024 12 | 58 | 9 | 67 |
| 2024 11 | 85 | 12 | 97 |
| 2024 10 | 66 | 25 | 91 |
| 2024 9 | 65 | 18 | 83 |
| 2024 8 | 76 | 28 | 104 |
| 2024 7 | 78 | 10 | 88 |
| 2024 6 | 50 | 11 | 61 |
| 2024 5 | 33 | 6 | 39 |
| 2024 4 | 63 | 6 | 69 |
| 2024 3 | 85 | 14 | 99 |
| 2024 2 | 63 | 14 | 77 |
| 2024 1 | 60 | 7 | 67 |
| 2023 12 | 54 | 22 | 76 |
| 2023 11 | 65 | 19 | 84 |
| 2023 10 | 53 | 19 | 72 |
| 2023 9 | 34 | 6 | 40 |
| 2023 8 | 16 | 4 | 20 |
| 2023 7 | 10 | 16 | 26 |
| 2023 6 | 19 | 3 | 22 |
| 2023 5 | 19 | 13 | 32 |
Show all
